ProPharma Acquires UK Based Digital Lab Consulting
ProPharma Group (ProPharma) the leading global provider of regulatory, clinical, and quality services for the life sciences industry, announces the acquisition of Digital Lab Consulting (DLC) – a global premier advisory company specializing in digital transformation expertise and innovative solutions for life sciences organizations.
The acquisition sees ProPharma further expand its global capabilities with the UK-based firm working across its full portfolio. Through the acquisition, ProPharma immediately expands its foundation of R&D technology services to include digital transformation, strategic roadmap development, system selection and high-level business analysis consulting. DLC has built a reputation as a strategic partner throughout the life sciences industry, providing business and technical consulting expertise and experience to enable organizations of all sizes to transform their business through better use of data and technology.
ProPharma, which unveiled itself as the world’s largest Research Consulting Organization (RCO) at the J.P. Morgan Health Conference earlier this month, has over 20 years’ experience in advancing scientific breakthroughs, helping its clients to bring life-saving medicines to market. Its revolutionary approach, which operates on an ‘advise-build-operate model’ breaks the mold of the traditional CRO by providing tailor-made consulting services to small and mid-size innovators, as well as larger players, globally. The new strategy and operating model are further supported by the launch of a global re-brand. Outlined in its recent White Paper, ProPharma is taking a bold leadership position in a dynamic industry and is confident the life sciences industry at large will benefit from its groundbreaking RCO model.
Michael Stomberg, CEO of ProPharma, said: “Digital Lab Consulting is a critical addition to our expanding suite of R&D Technology services. DLC will instantly propel ProPharma’s R&D Technology offerings globally and will help to establish ProPharma as the go-to digital innovation leader across the life sciences industry, further defining ProPharma’s RCO model.”
Dr. Eliot Randle and Roger Shaw, Co-Founders and Managing Partners of DLC, will join the leadership team as Senior Vice Presidents of Digital Transformation under ProPharma’s R&D Technology Business Unit. Randle and Shaw are accompanied by a team with over 25 years of experience across the entire pharma value chain.
Dr. Eliot Randle, Co-Founder of Digital Lab Consulting, said: “We’re excited to have found a partner in ProPharma that shares our passion for innovation. Under the ProPharma brand, we will combine our decades of experience and amplify our reach to help clients achieve their digital transformation goals.”
Roger Shaw, Co-Founder of Digital Lab Consulting, said: “Our identity and values align with ProPharma, and this acquisition will reinforce our position as the go-to digital partner for transformational-minded organizations by extending the DLC offerings across all ProPharma’s business lines.”
Companies In This Post
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more